Narcolepsy

• FDA approval · 2006-08-10
  FDA Approved: DEXEDRINE SPANSULE — Supplemental Application (Amneal Pharmaceuticals LLC)

  FDA approved a supplemental application for Dexedrine Spansule (dextroamphetamine sulfate) submitted by Amneal Pharmaceuticals LLC.

• FDA approval · 2006-08-08
  FDA Approved: METHYLPHENIDATE — Supplemental Application (Sandoz Inc)

  FDA approved a supplemental application for methylphenidate from Sandoz Inc, updating an already approved product.

• FDA approval · 2006-08-08
  FDA Approved: RITALIN — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approved a supplemental application for Ritalin (methylphenidate hydrochloride) submitted by Novartis Pharmaceuticals Corporation.

• FDA approval · 2006-08-07
  FDA Approved: MODAFINIL — Supplemental Application (CIMA LABS INC.)

  FDA approved a supplemental application for Modafinil submitted by CIMA Labs Inc., resulting in an approved change to its labeling.

• FDA approval · 2006-07-26
  FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)

  FDA approved a supplemental application from Prasco Laboratories for a product containing dextroamphetamine saccharate, amphetamine aspartat…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2006-06-30
  FDA Approved: SODIUM OXYBATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  The FDA approved a supplemental application for sodium oxybate from Hikma Pharmaceuticals USA Inc., signifying an approved update to the pro…

• FDA approval · 2006-06-16
  FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)

  FDA granted a supplemental approval to Prasco Laboratories for a mixed amphetamine salts product containing dextroamphetamine and amphetamin…